Additional file 9: Figure S4. of Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

Cell lines exhibit the expected ESR, PGR and ERBB2 marker expression status. Linear range of RSEM from ESR1 (upper), PGR1 (middle) and ERBB2 (lower) for the in house and external RNA-Seq datasets. Gray boxes below data indicate the study related to the dataset (in house, Varley et al. [25] and Daemen et al. [26]) (XLS 26 kb)